• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [1370 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2027 Belgian Health Care Knowledge Centre (KCE) Review of new oncology indications for the use of positron emission tomography (PET-scans) (Study 2024-12)
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [X-ray image of the lung: Can artificial intelligence support the analysis of X-ray images?]
2026 Swiss Federal Office of Public Health (FOPH) Superficial/deep heat in physiotherapy for musculoskeletal conditions
2026 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Artificial intelligence software to detect viable tissue in stroke patients on CT or perfusion MRI of the skull]
2026 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Neurosurgical robot for electrode implantation, brain biopsies and spinal surgery]
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Fundus photography for the diagnosis of diabetic retinopathy]
2025 Scottish Health Technologies Group (SHTG) Artificial intelligence-assisted clinician review of chest X-rays for suspected lung cancer
2025 HTA South [Observation after mild head injury in patients on anticoagulation therapy: a systematic review and assessment of medical, economical and ethical aspects]
2025 Institut national d'excellence en sante et en services sociaux (INESSS) [Fluoroscopic or endoscopic evaluation of dysphagia in adults]
2025 Institut national d'excellence en sante et en services sociaux (INESSS) [Prevention of hypersensitivity reactions to intravascular contrast media during medical imaging in adults]
2025 Institut national d'excellence en sante et en services sociaux (INESSS) [Cardiac ultrasound: current practices]
2025 The Danish Health Technology Council (DHTC) [Evaluation report concerning HAL-Guided transurethral resection of bladder tumors in adult patients with suspected non-muscle-invasive bladder cancer]
2025 NIHR Health Technology Assessment programme Clinical and cost-effectiveness of detailed anomaly ultrasound screening in the first trimester: a mixed-methods study
2025 Haute Autorite de sante (HAS) [Second-line non-invasive skin imaging techniques, including in vivo reflectance confocal microscopy (RCM), for the diagnosis and preoperative mapping of melanoma]
2025 NIHR Health Technology Assessment programme Software with artificial intelligence-derived algorithms for detecting and analysing lung nodules in CT scans: systematic review and economic evaluation
2025 Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Clinical follow-up of incidental pulmonary nodules: progress report on the selection of efficacy and safety indicators]
2025 Health Technology Wales (HTW) Long length peripheral intravenous catheters for patients with difficult intravenous access
2025 Institute of Health Economics (IHE) PET/CT capacity for cancer diagnosis and follow-up: rapid review
2025 Institut national d'excellence en sante et en services sociaux (INESSS) [Access to breast cancer screening for Québec women aged 40 to 49: issues, considerations and implementation approach]
2025 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Diagnostic accuracy of ex vivo confocal microscopy during Mohs surgery for basal cell carcinomas]
2025 Andalusian Health Technology Assessment Area (AETSA) [Impact of multidisciplinary hospital teams employing ultrasound-guided vascular access]
2025 NIHR Health Technology Assessment programme Variation within and between digital pathology and light microscopy for the diagnosis of histopathology slides: blinded crossover comparison study
2025 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Portable ultrasonic scanner to measure urine volume in the bladder in hospitalized adult patients with suspected urinary retention]
2025 NIHR Health Technology Assessment programme Stopping anticoagulation for isolated or incidental subsegmental pulmonary embolism: the challenges and lessons from the STOPAPE RCT
2025 Health Information and Quality Authority (HIQA) Magnetic resonance-guided radiotherapy (MRgRT) evidence synthesis to support a generic justification decision
2025 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment of cardiac magnetic resonance imaging in coronary heart disease]
2025 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Consumer health information on lung cancer screening using low-dose computed tomography]
2025 Agency for Care Effectiveness (ACE) EchoGo Heart Failure to aid in the diagnosis of heart failure with preserved ejection fraction
2025 Norwegian Medical Products Agency (NOMA) [Magnetic resonance guided high-intensity focused ultrasound for treatment of essential tremor: single technology assessment]
2025 Norwegian Medical Products Agency (NOMA) [Photon-counting detector computed tomography]
2024 HTA Region Stockholm [Comparing coronary computed tomography angiography (CCTA) to exercise electrocardiogram for suspected coronary artery disease: impact on patient outcomes]
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: evaluation of the lung cancer screening pilot project - effects on participants' health and organizational impact on the healthcare system]
2024 Health Information and Quality Authority (HIQA) Evidence review of universal ultrasound screening for developmental dysplasia of the hip (DDH) in infants in Ireland
2024 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment of lung cancer screening using low-dose computed tomography]
2024 Health Information and Quality Authority (HIQA) Magnetic resonance imaging-guided radiotherapy: Protocol for an evidence review to inform generic justification
2024 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Multi-stage evaluation and revision of information materials on the mammography screening programme]
2024 The Regional Health Technology Assessment Centre (HTA-centrum) Benefits and risks of using laparoscopic ultrasonography versus intraoperative cholangiography during laparoscopic cholecystectomy for gallstone disease
2024 National Evidence-based Healthcare Collaborating Agency (NECA) [Magnetic resonance imaging-guided transurethral ultrasound ablation of localized prostate cancer]
2024 Scottish Health Technologies Group (SHTG) FDG-PET imaging in the diagnosis of dementia
2024 National Evidence-based Healthcare Collaborating Agency (NECA) [Artificial intelligence-based screening test for emergent large vessel occlusion using non-contrast brain CT images]
2024 Ontario Health Single-exposure, dual-energy subtraction flat panel x-ray detectors
2024 National Evidence-based Healthcare Collaborating Agency (NECA) [Real time high resolution MR image guidance during irradiation]
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: imaging of the spine for the investigation of low back pain]
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: initiating osteodensitometry following the assessment of fracture risk with the FRAX tool]
2024 Health Technology Wales (HTW) Artificial Intelligence (AI)-assisted endoscopy in the detection of gastrointestinal cancer and pre-cancerous lesions
2024 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Gadopiclenol (contrast-enhanced magnetic resonance imaging) – Benefit assessment according to §35a Social Code Book V]
2024 Health Technology Wales (HTW) Artificial intelligence assisted tools for prostate cancer diagnosis using whole slide biopsy images
2024 Belgian Health Care Knowledge Centre (KCE) Lung cancer screening in a high-risk population
2024 Belgian Health Care Knowledge Centre (KCE) Diagnostic Immunohistochemistry and electron microscopy testing in Belgium
2024 NIHR Health Technology Assessment programme Development and evaluation of machine-learning methods in whole-body magnetic resonance imaging with diffusion weighted imaging for staging of patients with cancer: the MALIBO diagnostic test accuracy study
2024 Malaysian Health Technology Assessment (MaHTAS) Wide field digital eye imaging system for universal neonatal eye screening
2024 NIHR Health Technology Assessment programme Doppler ultrasound surveillance of recently formed haemodialysis arteriovenous fistula: the SONAR observational cohort study
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: breast cancer screening with breast tomosynthesis]
2024 Malaysian Health Technology Assessment (MaHTAS) Computer aided-detection or artificial intelligence for chest X-ray in early detection of tuberculosis
2024 Scottish Health Technologies Group (SHTG) Digital fracture liaison service
2024 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Radiofrequency echographic multi-spectrometry for bone mineral density assessment]
2024 Health Technology Wales (HTW) Digital tools for the monitoring and management of wounds
2024 Ontario Health Single-exposure, dual-energy subtraction flat panel x-ray detectors: a health technology assessment
2024 National Institute for Health and Care Excellence (NICE) Image-guided percutaneous laser ablation for primary and secondary liver tumours. NICE interventional procedures guidance 788
2024 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Fracture sonography in children with suspected fracture of a long tubular bone of the upper extremities]
2024 NIHR Health Technology Assessment programme Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis
2024 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Gozetotide (positron emission tomography, prostate cancer [mCRPC]) – Benefit assessment according to § 35a Social Code Book V]
2024 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Decision support software in ultrasound diagnosis for the classification of breast nodules]
2024 NIHR Health and Social Care Delivery Program Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT
2024 NIHR Health and Social Care Delivery Program Real-time ultrasound elastography in the diagnosis of newly identified thyroid nodules in adults: the ElaTION RCT
2024 NIHR Health and Social Care Delivery Program Artificial intelligence software for analysing chest X-ray images to identify suspected lung cancer: an evidence synthesis early value assessment
2024 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: medical imaging of the head]
2024 WorkSafeBC Efficacy/effectiveness of brain mapping in treating concussions
2024 NIHR Health Technology Assessment programme A cloud-based medical device for predicting cardiac risk in suspected coronary artery disease: a rapid review and conceptual economic model
2024 National Institute for Health and Care Excellence (NICE) MRI-guided focused ultrasound thalamotomy for treating moderate to severe tremor in Parkinson's. NICE interventional procedures guidance 796
2024 National Institute for Health and Care Excellence (NICE) MRI-guided focused ultrasound subthalamotomy for treating Parkinson's. NICE interventional procedures guidance 797
2024 Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Point-of-care ultrasound for the evaluation of pulmonary volume overload in an outpatient setting]
2024 Center for Drug Evaluation (CDE) [HTA Full report-Cost-effectiveness analysis of adjusting the age and frequency of mammography subsidies]
2024 NIHR Health and Social Care Delivery Program Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT
2024 Agency for Care Effectiveness (ACE) FEops HEARTguide for procedure planning in patients needing transcatheter left atrial appendage occlusion (LAAO) device
2024 NIHR Health Technology Assessment programme Transperineal biopsy devices in people with suspected prostate cancer - a systematic review and economic evaluation
2024 NIHR Health Technology Assessment programme MRI software and cognitive fusion biopsies in people with suspected prostate cancer: a systematic review, network meta-analysis and cost-effectiveness analysis
2024 NIHR Health Technology Assessment programme Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis
2024 Institute for Clinical Effectiveness and Health Policy (IECS) [Magnetic resonance neurography in peripheral neuropathy or plexopathy]
2024 HTA South [Artificial intelligence in breast cancer screening with mammography]
2023 HTA South [Focused ultrasound treatment for tremor]
2023 Austrian Institute for Health Technology Assessment (AIHTA) Image-guided spinal injections in the treatment of chronic spinal pain: an overview of evidence-based guideline recommendations and specific focus on guidance techniques
2023 National Evidence-based Healthcare Collaborating Agency (NECA) [Intraoperative CT imaging system for navigational spine surgery]
2023 National Evidence-based Healthcare Collaborating Agency (NECA) [Magnetic resonance imaging-guided transurethral ultrasound ablation of prostatic hyperplasia]
2023 Institute for Clinical Effectiveness and Health Policy (IECS) [Triple-phase computed tomography in patients with liver lesion]
2023 Institute for Clinical Effectiveness and Health Policy (IECS) [Transbronchial biopsy guided by endobronchial ultrasound (EBUS) in pathologies accesible by transbronchial puncture that required anatomopathological diagnosis]
2023 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Electromagnetic Navigation Bronchoscopy: Use in Dying for Lung Nodules Resection. Horizon Scanning Technologies]
2023 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Robotic Bronchoscopy for Lung Nodule Diagnostics. Horizon Scanning Technologies]
2023 Malaysian Health Technology Assessment (MaHTAS) Ultra-portable digital x-ray system for TB screening
2023 Canary Health Service [Conduction system pacing implantation through electroanatomical mapping-guided vs. fluoroscopy]
2023 Institute of Health Economics (IHE) Optimizing MRI service capacity: review of the relationship between MRI delay and outcomes
2023 NIHR Health Technology Assessment programme Impact of multiparametric MRI on staging and management of patients with suspected or confirmed ovarian cancer Short title: MR in Ovarian Cancer (MROC study)
2023 NIHR Health Technology Assessment programme Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial
2023 Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) Thermidas thermal imaging system
2023 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Insertion of peripherally inserted central catheter with reservoir (PICC-port) in patients diagnosed with solid and hematological tumors with indication for chemotherapy]
2023 NIHR Health Technology Assessment programme Clinical and cost effectiveness of endoscopic bipolar radiofrequency ablation for the treatment of malignant biliary obstruction: a systematic review
2023 The Danish Health Technology Council (DHTC) [Assessment of pocket-sized handheld ultrasound devices for point-of-care examination of patients in emergency departments]
2023 Health Information and Quality Authority (HIQA) 18F-PSMA PET/CT in the staging of primary prostate cancer and the restaging of recurrent prostate cancer: evidence synthesis to support a generic justification decision
2023 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Stereotactic virtual navigation systems for percutaneous tumour ablation]
2023 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [UAE and MRgFUS versus myoma enucleation - Evidence report for the S3 guideline on diagnosis and treatment of benign diseases of the uterus]